Postmortem toxicology of drugs of abuse.
Conducting toxicology on post-mortem specimens provides a number of very significant challenges to the scientist. The range of additional specimens include tissues such as decomposing blood and other tissues, hair, muscle, fat, lung, and even larvae feeding on the host require special techniques to isolate a foreign substance and allow detection without interference from the matrix. A number of drugs of abuse are unstable in the post-mortem environment that requires careful consideration when trying to interpret their significance. Heroin, morphine glucuronides, cocaine and the benzodiazepines are particularly prone to degradation. Moreover, redistributive process can significantly alter the concentration of drugs, particularly those with a higher tissue concentration than the surrounding blood. The designer amphetamines, methadone and other potent opioids will increase their concentration in blood post-mortem. These processes together with the development of tolerance means that no concentration of a drug of abuse can be interpreted in isolation without a thorough examination of the relevant circumstances and after the conduct of a post-mortem to eliminate or corroborate relevant factors that could impact on the drug concentration and the possible effect of a substance on the body. This article reviews particular toxicological issues associated with the more common drugs of abuse such as the amphetamines, cannabinoids, cocaine, opioids and the benzodiazepines.
Drummer
Olaf H
OH
Department of Forensic Medicine, Victorian Institute of Forensic Medicine, Monash University, 57-83 Kavanagh Street, Southbank, 3006 Melbourne, Australia. olaf@vifm.org
D000662:Amphetamines / Q000032:analysis / Q000493:pharmacokinetics / Q000506:poisoning; D000701:Analgesics, Opioid / Q000032:analysis / Q000493:pharmacokinetics / Q000506:poisoning; D001569:Benzodiazepines / Q000032:analysis / Q000493:pharmacokinetics / Q000506:poisoning; D002188:Cannabis / Q000506:poisoning; D003042:Cocaine / Q000032:analysis / Q000493:pharmacokinetics / Q000506:poisoning; D018765:Dopamine Uptake Inhibitors / Q000032:analysis / Q000493:pharmacokinetics / Q000506:poisoning; D005554:Forensic Medicine / Q000379:methods*; D003932:Heroin / Q000032:analysis / Q000493:pharmacokinetics / Q000506:poisoning; D006801:Humans; D011180:Postmortem Changes; D013048:Specimen Handling; D015813:Substance Abuse Detection / Q000379:methods*; D019966:Substance-Related Disorders / Q000097:blood / Q000652:urine
D000662:Amphetamines; D000701:Analgesics, Opioid; D018765:Dopamine Uptake Inhibitors; D001569:Benzodiazepines; D003932:Heroin; D003042:Cocaine